Tag: NuVasive
NuVasive celebrates 20-year milestone of the XLIF procedure
NuVasive has, this week, announced the 20-year milestone achievement of its lateral lumbar procedure, extreme lateral interbody fusion (XLIF).
Ryan Donahoe, chief technology officer at...
NuVasive and Globus Medical announce merger
NuVasive and Globus Medical have revealed that they have entered into a definitive agreement to combine in an all-stock transaction. Under the terms of...
NuVasive launches Tube System and Excavation Micro for posterior spine surgery
NuVasive has announced the commercial launch of the NuVasive Tube System (NTS) and Excavation Micro, a new minimally invasive surgery (MIS) system that the...
NuVasive launches Reline Cervical for posterior cervical fusion
NuVasive has announced the expansion of its C360 portfolio following the commercial launch of Reline Cervical, a new fixation system for posterior cervical fusion (PCF),...
NuVasive announces departure of chief commercial officer
NuVasive recently announced the resignation of its executive vice president and chief commercial officer, Massimo Calafiore. Calafiore will be leave NuVasive on August 31 to...
NuVasive porous titanium interbody implant and synthetic bone graft substitute a...
The use of entirely synthetic solutions featuring porous titanium interbody implants and a bone graft substitute have clinical and economic advantages compared with traditional, non-porous...
Data show superiority of Simplify cervical disc compared to ACDF for...
Results from a two-level multicentre US Food and Drug Administration (FDA) investigational device exemption (IDE) study have shown superior outcomes with the Simplify cervical...
Why the Pulse platform is a “game-changer” for spine surgery
This advertorial is sponsored by NuVasive.
The field of spine surgery has seen some major developments over the past few years, with new technological advances...
NuVasive announces expanded indications of use for Attrax Putty
NuVasive has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax Putty with its...
NuVasive launches latest porous PEEK implant for posterior spine surgery
NuVasive has announced the launch of its Cohere TLIF-O implant as well as the upcoming launch later this year of the Cohere TLIF-A implant....
First commercial cases completed using Pulse platform
Michael Kachmann and Zachary Tempel from Mayfield Brain & Spine (Norwood, USA) and Paul Holman from Houston Methodist Hospital (Houston, USA) have successfully completed...
NuVasive announces new executive leadership roles
NuVasive has announced new executive leadership roles, with the appointments designed to strengthen the firm’s innovation and go-to-market teams while furthering the company's growth.
Massimo...
NuVasive receives FDA clearance for Pulse platform and announces commercial launch
NuVasive has announced that it has received US Food and Drug Administration 510(k) clearance for its Pulse platform, after receiving CE mark certification earlier...
NuVasive receives CE Mark for Pulse platform and begins global clinical...
NuVasive has revealed that its Pulse platform received CE Mark approval for its latest design update and clinical evaluations are now underway in multiple...
NuVasive’s Simplify Disc gains FDA approval for use in two-level cTDR
NuVasive has gained FDA approval for its Simplify Cervical Artificial Disc, allowing the device to be used in two-level cervical total disc replacement (cTDR)...
NuVasive and the International Spine Study Group Foundation announce two new...
NuVasive and the International Spine Study Group Foundation (ISSGF) have announced the continuation of their long-term partnership by launching two new clinical studies focused...
NuVasive acquires Simplify Medical
NuVasive has acquired Simplify Medical, a privately-held company and developer of the Simplify Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR).
According...
Study finds single-position spine surgery improves operative efficiency while reducing complications...
NuVasive has announced that a new study published in The Spine Journal could validate single-position spine surgery as having significant advantages over traditional, open...
Nuvasive announces C360 cervical spine portfolio
NuVasive has announced the launch of its C360 cervical spine portfolio, which includes the commercial launch of its Anterior Cervical Plating (ACP) system. The...
NuVasive launches Reline 3D for paediatric spinal deformity
NuVasive has today announced the expansion of its complex spine portfolio with the global commercial availability of Reline 3D, a posterior fixation system for...
NuVasive expands Advanced Materials Science implant portfolio
NuVasive has announced the expansion of its Advanced Materials Science (AMS) implant portfolio with the commercial launch of the Modulus XLIF dual sided plate,...
UK regulator review sees NuVasive suspend supply of Magec rods
NuVasive has suspended the supply of all Magec rods to the UK and Ireland while the UK’s Medicines and Healthcare products Regulatory Agency (MHRA)...
Study supports use of Attrax Putty as substitute for autograft
NuVasive has announced the results of a study supporting the use of Attrax Putty as a standalone bone graft substitute for autograft in instrumented...
Preliminary results validate NuVasive’s MaXcess retractor in prone single-position XLIF and...
NuVasive has announced the results of a study published in The European Spine Journal, validating the versatility of its MaXcess retractor in prone, single-position...
NuVasive appoints Matthew Harbaugh as chief financial officer
Nuvasive has announced the appointment of Matthew K Harbaugh as executive vice president and chief financial officer (CFO) effective immediately. Harbaugh succeeds Rajesh J...
NuVasive receives FDA clearance for expanded multi-level use of CoRoent small...
NuVasive has received US Food and Drug Administration (FDA) 510(k) clearance for expanded indications for the CoRoent small interlock system. The expanded indication allows...
NuVasive launches Pulse integrated technology platform
NuVasive has announced the launch of its Pulse integrated technology platform. According to a press release, “Pulse is the first, single platform to include...
NuVasive announces new organisational structure and leadership team
NuVasive today announced a new organisational structure and associated executive team that chief executive officer J Christopher Barry has selected. Barry joined the company...
Expanded FDA clearance for NuVasive’s Monolith corpectomy system
The Monolith corpectomy system (NuVasive) has been granted expanded FDA 510(k) clearance.
The system is now cleared for procedures in the cervical spine, between the...
Global orthopaedic devices market worth US$47.7 billion by 2026
The "Orthopaedic devices market size, share and trends analysis report by application (hip, knee, spine, cranio-maxillofacial, dental, SET), by product (accessories, surgical devices), and segment...
NuVasive launches Brigade Lateral implant and instrumentation optimised for lateral ALIF...
NuVasive has announced the US commercial launch of Brigade Lateral, the industry's first interbody implant and instrumentation optimised for lateral anterior lumbar interbody fusion...
NuVasive’s Porous PEEK impant to be used in flagship XLIF procedure
NuVasive has announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for use of its COHERE Porous PEEK implant...
NuVasive announces strategic partnership with Biedermann Technologies to access intellectual property
NuVasive have announced it has entered into a strategic partnership with Biedermann Technologies, a company that holds a broad and extensive patent and technology...
NuVasive unveils spine’s first integrated surgical automation platform
NuVasive has announced the Pulse surgical automation platform has received 510(k) clearance from the US Food and Drug Administration (FDA). Pulse is the foundation...
NuVasive and Siemens Healthcare to partner on new spine imaging and...
NuVasive and Siemens Healthineers have announced a strategic partnership, which is to focus on “technology development, marketing and commercial activities to advance clinical outcomes...
Next generation Reline system launches
The next evolution of the Reline system (NuVasive) has just launched: the Reline MAS Midline (RMM). The company description says this system provides “procedural...
Research highlights the importance of spinal alignment in all, not just...
The results of a report looking at the rates of spinopelvic malalignment in nearly 600 patients show that malalignment is common both before and...
First porous PEEK spinal implant clinical study validates its use in...
Porous polyetheretherketone (PEEK) technology (NuVasive) is a clinically viable alternative for improving osseointegration and fusion rates of interbody implants to treat degenerative cervical disc...
Research shows NuVasive porous PEEK structure maintains high porosity after impaction
The NuVasive porous polyether-ether-ketone (PEEK) material shows minimal surface damage upon impaction compared to titanium-coated devices, concludes a study recently published in The Spine...
Scoliosis Research Society collaborates with corporate partners and International Spine Study...
The Scoliosis Research Society (SRS) has partnered with Globus Medical, K2M, Medtronic, NuVasive, Zimmer Biomet, and the International Spine Study Group Foundation (ISSGF) to...
NuVasive extends porous PEEK interbody to TLIF and PLIF procedures
NuVasive announced on 4 January the launch of the company’s Coalesce Thoracolumbar Interbody Fusion Device as well as FDA 510(k) clearance for expanded indications of...
Nuvasive launches 3D-printed porous titanium implant Modulus XLIF
Medical device company Nuvasive have launched a new porous titanium interbody implant for their XLIF procedures, named the Modulus. The Modulus XLIF device is...
US FDA clears Nuvasive’s redesigned Magec system
NuVasive has received 510(k) clearance from the US Food and Drug Administration (FDA) for use of the company's redesigned Magec system with its Reline...
NuVasive announces market launch of LessRay
NuVasive has launched the LessRay software technology system commercially. Comprised of a propriety software algorithm and hardware components, it is designed to help address...
NuVasive acquires Vertera Spine
NuVasive has announced the company's acquisition of Vertera Spine, a privately-held medical device company developing and commercialising interbody implants for spinal fusion using patented...
NuVasive to open innovation centre in San Diego, USA
NuVasive has announced the expansion of its San Diego global headquarters, including the creation of an innovation centre of excellence. Surgeons from around the...
Rajesh J Asarpota appointed as Nuvasive’s chief financial officer
NuVasive has announced the appointment of Rajesh (Raj) J Asarpota as the company's new executive vice president and chief financial officer (CFO), effective September...
Dennis Cirino: Achieving alignment beyond preoperative planning
Dennis Cirino, NuVasive's vice president of Computer-Asissted surgery, spoke to Spinal News International at NSpine 2017 about the importance of alignment in both deformity...
Dominique Rothenfluh: “We need to understand how the whole spine behaves”
Dominique Rothenfluh (Oxford, UK) discusses the importance of considering alignment in spinal surgery at NSpine 2017. The alignment of the entire spine, he explains,...
Behrooz Akbarnia: “A game-changer for early onset scoliosis”
Spinal News International caught up with with Behrooz Akbarnia (La Jolla, USA) at NSpine 2017 (12–15 July; London, UK) to talk about the challenges...
Ultra-low radiation imaging with image-enhancement software “substantially decreases” radiation dosage
The dangers of radiation exposure to patients and operating room staff are well-publicised. With the advent of minimally invasive spine surgery, both patient and...
NuVasive appoints Skip Kiil executive vice president, International
NuVasive has announced that Skip Kiil is joining the company as executive vice president, International. In this role, Kiil will oversee the company's international...
NuVasive launches Reline Trauma portfolio
NuVasive has announced the launch the new Reline Trauma portfolio, which is designed to provide surgeons the flexibility to customise their approach intraoperatively, including...
First-time US FDA clearance for Nuvasive’s greater than two-level cervical interbody...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Nuvasive for the CoRoent small interbody system indicated for intervertebral body fusion...
Nuvasive’s XLIF receives new Japanese Ministry of Health, Labour and Welfare...
NuVasive has received approval for instruments used in the Extreme Lateral Interbody Fusion (XLIF) procedure by the Japanese Ministry of Health, Labour and Welfare...
NuVasive expands IGA platform to support all spinal procedures
NuVasive has launched a number of new spinal innovations, including the company’s expanded Integrated Global Alignment (IGA) platform, which now supports all spinal procedures,...
NSpine 2017 early bird registration opens with International Philipp Zorab Symposium...
Early bird registration for NSpine 2017 has opened, offering discounted registration until 30th November.
NSpine is collaborating with the British Scoliosis Research Foundation and NuVasive...
NuVasive receives US FDA 510(k) clearance for the Magec implantation using...
NuVasive has received 510(k) clearance from the US Food and Drug Administration (FDA) for the company’s Magec system to be surgically implanted using its...